Unclaimed
Pius N. Nde
Is this your partnering profile? Claim & update it for free.
This profile was programmatically compiled from public sources. Take control to ensure accuracy, share updates, and connect with industry R&D teams.
About
At Meharry Medical College, I study RNA-mediated regulation, host-pathogen interactions, and cardiac and vascular disease. My group integrates computational biology and multi-omics to map pathways, discover circulating biomarkers, and examine developmental programming of neonatal inflammation.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.
Connecting the dots between FXR1 isoforms and miR-1 in pediatric dilated cardiomyopathy
AJP Heart and Circulatory Physiology
•2025
Implementation of an Integrated Active Learning PhD Curriculum in Biomedical Science
2025
Building Graduate Student Skills and Networks through the SHort course In transFerable skills Training (SHIFT) Program
2025
Identifying Plasma Proteins Linked to Neutrophil Activationin Abdominal Aortic Aneurysm
2025
Abstract We0015: Plasma Protein Predictors of Abdominal Aortic Aneurysm Growth
2025
Regulatory roles of PIWI-interacting RNAs in cardiovascular disease
American Journal of Physiology-Heart and Circulatory Physiology
•2025
Regulatory roles of PIWI-interacting RNAs (piRNAs) in cardiovascular disease
2025
Abstract 2467 ZAR1L Protein: Stress Granule Dynamics and Chemotherapy Resistance in Breast Cancer
2024
Trypanosoma cruzi dysregulates expression profile of piRNAs in primary human cardiac fibroblasts during early infection phase
Frontiers in Cellular and Infection Microbiology
•2023
Xanthine Analogs Suppress Trypanosoma cruzi Infection In Vitro Using PDEs as Targets
Microbiology Research
•2022
Abstract P1078: Early <i>Trypanosoma Cruzi</i> Infection Of Heart Endothelial Cells Modulates Hippo And Wnt Signaling Pathways In TSP-1 Dependent Manner
2022
<i>Trypanosoma cruzi</i> dysregulates expression of piRNA that can regulate IL‐6 signaling in human cardiac fibroblasts during the early phase of infection
2022
No funding yet
This innovator hasn't added funding yet. In the meantime, you might want to explore their publications, patents, and other profile details.
No patents yet
This innovator hasn't added patents yet. In the meantime, you might want to explore their publications, funding, and other profile details.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.